Company Monitoring Page for Biogen

latest headlines for company on cafepharma

Does Lilly's Alzheimer's Fail Hurt Biogen?
Investopedia
Fri, 11/25/16 - 09:22 am
Tags:
Biogen, Eli Lilly, Alzheimer's disease, solanezumab
Biogen loses $4 billion in market cap on Eli Lilly Azheimer's news
Bizjournals.com
Wed, 11/23/16 - 12:05 pm
Tags:
Biogen, Eli Lilly, Alzheimer's disease, solanezumab
$13 Billion Opportunity: 5 Companies That Could Dominate the Alzheimer's Disease Market
Motley Fool
Mon, 11/21/16 - 02:35 pm
Tags:
Alzheimer's disease, AstraZeneca, Biogen, Eli Lilly, Merck, Roche, BACE inhibitors
What puts a new drug launch in line for victory? Ask Gilead, Biogen and J&J
Fierce Pharma
Thu, 11/17/16 - 10:01 am
Tags:
Gilead Sciences, Biogen, JNJ, drug launches, AbbVie, Sovaldi, Imbruvica, Tecfidera
Biogen's Growth Is Far Weaker Than You May Think
Motley Fool
Wed, 11/9/16 - 09:37 am
Tags:
Biogen, earnings
Poised to launch a new drug for SMA, Biogen and Ionis shares jump on more promising PhIII data
Endpoints
Mon, 11/7/16 - 09:42 am
Tags:
Biogen, Ionis, spinal muscular atrophy, Nusinersen
Biogen’s Tecfidera, Amgen’s Enbrel tell a tale of pricing power and weakness
Fierce Pharma
Mon, 10/31/16 - 09:40 am
Tags:
Biogen, Tecfidera, Amgen, Enbrel, drug pricing
Here's Why Biogen Should Buy Ionis Pharmaceuticals
Motley Fool
Sat, 10/29/16 - 01:18 pm
Tags:
Biogen, Ionis Pharmaceuticals, R&D, George Scangos
Biogen stock lifts as much as 3% as MS drugs propel third-quarter beat
Marketwatch
Thu, 10/27/16 - 09:00 am
Tags:
Biogen, earnings
Novartis' Is Challenging Biogen on Biogen's Own Turf
Motley Fool
Wed, 10/26/16 - 09:19 pm
Tags:
Novartis, Biogen, Gilenya, Tecfidera, MS, multiple sclerosis
Biogen quietly whisks away its $544M autoimmune rival to Celgene
Endpoints
Wed, 10/26/16 - 09:28 am
Tags:
Biogen, Celgene, autoimmune disease, amiselimod, ozanimod
Here's the big news we're likely to hear when Vertex, Biogen report Q3 this week
Bizjournals.com
Mon, 10/24/16 - 09:37 am
Tags:
earnings, Vertex Pharmaceuticals, Biogen
What Biogen Is Doing that Put It in Good Favor with Analysts
Market Realist
Thu, 10/20/16 - 09:22 am
Tags:
Biogen
Powerful Dems orchestrated campaign at FDA to provide Biogen drug to a dying, high-profile fundraiser
Endpoints
Sun, 10/16/16 - 12:32 pm
Tags:
FDA, Biogen, Multiple Myeloma, compassionate use guidelines
Departing Novo chief wins 'best CEO' nod again, and Biogen's grabs laurels, too
Fierce Pharma
Thu, 10/13/16 - 10:56 am
Tags:
Pharma CEOs, Novo Nordisk, Biogen, Lars Sorenson, George Scangos
3 Biotechs Most Likely to Be Acquired
Motley Fool
Tue, 10/11/16 - 09:45 pm
Tags:
biotech, M&A, Incyte, Biomarin, Biogen
Top 6 Biopharma Gainers of the Past Week
24/7 Wall St
Tue, 10/4/16 - 10:20 am
Tags:
Catabasis, Sarepta Therapeutics, Anavex, Biogen, Array Biopharma, GW Pharma
Big Pharma vs Big Pharma in court battles over biosimilar drugs
Yahoo/Reuters
Mon, 10/3/16 - 09:58 am
Tags:
Big Pharma, patents, biosimilars, Novartis, Amgen, Biogen, Sanofi, Merck, Eli Lilly, Pfizer, JNJ
Biogen Submits NDA for SMA Drug (BIIB, IONS)
Investopedia
Thu, 09/29/16 - 08:12 am
Tags:
Biogen, SMA, spinal muscular atrophy, Ionis Pharmaceuticals, Nusinersen
Could This Alzheimer’s Disease Drug Really Be Worth $20 Billion?
Motley Fool
Mon, 09/19/16 - 03:41 pm
Tags:
Biogen, Alzheimer's disease, aducanumab

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.